Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US needs to invest more in new technology for diabetes care

This article was originally published in Clinica

Executive Summary

The US allocated $1.32bn to medical expenditure and lost productivity in 2001 compared, to $98bn in 1997, according to a new study by the American Diabetes Association (ADA). The direct medical costs of diabetes more than doubled during the same period, from $44bn in 1997 to $91.8bn in 2002, the group said. Greater preparedness to use new technologies would result in lower healthcare costs and better productivity, believes the ADA.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061352

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel